What is PharmaResearch Co. Ltd.'s contact information?

PharmaResearch Co. Ltd.'s contact information: +82336457640.

How many employees does PharmaResearch Co. Ltd. have?

PharmaResearch Co. Ltd. has 89 employees.

What industry does PharmaResearch Co. Ltd. belong to?

PharmaResearch Co. Ltd. is in the industry of: Pharmaceuticals, Biotechnology, Health And Wellness.

What are PharmaResearch Co. Ltd.'s official social media profiles?

PharmaResearch Co. Ltd. Linkedin Page

What tech stack does PharmaResearch Co. Ltd. use?

Some of the popular technologies that PharmaResearch Co. Ltd. uses are: Google Analytics, Naver Analytics, jQuery CDN, jsDelivr, Gnuboard.

What are PharmaResearch Co. Ltd.'s office addresses?

PharmaResearch Co. Ltd. has 2 known office addresses: 62, Pangyo-ro, 255beon-gil, Bundang-gu Seongnam-si, Gyeonggi-do 13486, KR 62, Pangyo-ro, 255beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 13486, Kr.

What is PharmaResearch Co. Ltd.'s estimated annual revenue?

PharmaResearch Co. Ltd.'s revenue is $1,719,000

What is PharmaResearch Co. Ltd.'s open headcount?

PharmaResearch Co. Ltd. has 3 job postings.

What is the number of ad campaigns for PharmaResearch Co. Ltd.?

PharmaResearch Co. Ltd. has no advertisements yet.

What is the number of recent news articles about PharmaResearch Co. Ltd.?

PharmaResearch Co. Ltd. has 19 news articles.

PharmaResearch Co. Ltd. - Pubrio Company Profile & Intent

PharmaResearch Co. Ltd.

South Korea · Pharmaceuticals

Pharmaceuticals

Biotechnology

Health And Wellness

PharmaResearch Co., Ltd. is a biopharmaceutical company leading the regenerative Rx, OTC, Medical Device, Cosmetics and Dietary supplement technology and their market.

Company Insights

choicenews.co.kr · one day ago

Open news

KOSDAQ Surges 6.06% on Foreign Buying

KOSDAQ surged 6.06% to 1116.18 on April 1, driven by foreign and institutional buying. Battery, biotech, semiconductor, and optical communication stocks rallied significantly.

docdocdoc.co.kr · receives_financing · 2 weeks ago

Open news

Conext raises $12.5M in Series C funding

Conext raised $12.5M in Series C funding, with PharmaResearch as a strategic investor. Funds will accelerate clinical trials for Dupuytren's contracture treatment.

manilatimes.net · partners_with · 2026-02-11

Open news

PharmaResearch signs Rejuran supply deal in Brazil

PharmaResearch Co., Ltd. has entered an exclusive supply agreement with DermaDream, a Brazilian company, for Rejuran, a regenerative medicine product.

khgames.co.kr · is_developing · 2026-03-03

Open news

Bitcoin option investors bet on downside despite price rise

Bitcoin ETF and crypto-holding firms are buying put options to hedge against potential price drops below $60,000, despite recent price increases.

khgames.co.kr · is_developing · 2026-03-03

Open news

Bitcoin's 'Death Cross' Appears: Future Trends?

Bitcoin chart shows 'death cross' pattern, historically preceding major price drops. Despite this, ETFs see $1 billion inflow and long-term investors continue accumulating.

coinreaders.com · launches · 2026-03-02

Open news

JPMorgan: Crypto Market Structure Act likely to pass mid-year

JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.

Get full access to view complete information

1 - 19 of 19

Frequently Asked Questions Regarding PharmaResearch Co. Ltd.

Company Overview

1993

Founded

Pharmaceuticals

Industry

South Korea

Location

3,934,987

Ranking

89 employees

Size

Similar Companies

Get full access to view complete information